Title: Treating Acute Myeloid Leukemia with Pre-Existing Comorbidities

Speaker: 

Kayla Aufiero, PharmD, Hematology/Oncology Clinical Pharmacist, Geisinger - has nothing to disclose.

Moderator: 

Tristan Maiers, PharmD, BCOP, PGY2 Oncology Pharmacy Director, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• • Define standard AML treatment

• • Discuss management of AML in patients with pre-existing comorbidities

• • Identify pre-existing comorbidities that present as barriers in AML treatment

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Tristan Maiers, PharmD, BCOP, Activity Director, Rajiv Panikkar, MD, Michele Long, MS, BSN, OCN, Jaime Weeder, CRNP, Christopher Kashi, PA-C and Caitlin McDonald, CPht, CVT have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.